Enhancing brand performance; research shows best sales and marketing strategies

12 February 2007

After a decade of pooling resources into R&D, pharmaceutical companies are ready to see their drug on the shelves of pharmacies, physician clinics and patients' homes. To get to that stage, drugmakers must hire the appropriate number of sales representatives to research which specific segments of the pharmaceutical market should be targeted, and they should emphasize clinical and scientific excellence. Best Practices has conducted a study, Enhancing Brand Performance Through Sales & Marketing Excellence, to help companies in this.

Brand executives from 12 pharmaceutical companies, including Eli Lilly, Pfizer and Merck, were interviewed regarding winning strategies of leading brands in highly-competitive markets. The key topic areas included: efficient field force promotion, marketing strategies, promotional resource allocation and critical success factors.

Critical success factors included: maintaining quality and high share of voice through effective targeting, frequency and coordination in field force promotion; deploying many educational meetings and programs to maximize customer access and impact.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight